Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience.

Autor: Rahhal A; Pharmacy Department, Hamad Medical Corporation, Doha, Qatar., Najim M; Internal Medicine Department, Rochester Regional Health - Unity Hospital, New York, USA., Mahfouz A; Pharmacy Department, Hamad Medical Corporation, Doha, Qatar., Habib MB; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., Hassen SS; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., Al-Shekh I; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., Ahmed AO; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., Toba H; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., Abbarh S; Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar., El Hassan M; Critical Care Department, Hamad Medical Corporation, Doha, Qatar., Al Yafei S; Pharmacy Department, Hamad Medical Corporation, Doha, Qatar., Badr A; Heart Failure Department, Hamad Medical Corporation, Doha, Qatar., Mahmoud KM; Nephology Department, Hamad Medical Corporation, Doha, Qatar.; Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Publikováno v: Open medicine (Warsaw, Poland) [Open Med (Wars)] 2023 Dec 06; Vol. 18 (1), pp. 20230868. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).

EE285 Cost-Effectiveness of Evolocumab Versus Standard Therapy for the Treatment of Dyslipidemia in Patients with Cardiovascular Disease in Qatar

Autor: AlMukdad, S, Kaddoura, R, Arabi, AR, AlMaraghi, F, Al-Saadi Al Yafei, S, Al-Badriyeh, D

Publikováno v: In Value in Health July 2022 25(7) Supplement:S389-S389

Surrogates of the Left Ventricular Thrombus Resolution: A Retrospective Data Review.

Autor: Salah Shabib Ahmed H; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Ede H; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Sobhy Hassan Ghonim Mahfouz A; Department of Pharmacology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Abdullah Ali Rahhal A; Department of Pharmacology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Abdulhakim Ali M; Department of Pharmacology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Fares Alhaj Issa A; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Baki Jasem Senjar A; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Mehdar Al-Saadi Al Yafei S; Department of Pharmacology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Rahman Mohammad Said Arabi A; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar., Razaq Al-Qahtani A; Department of Cardiology, Hamad Medical Corporation Heart Hospital, Doha, Qatar.

Publikováno v: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir [Turk Kardiyol Dern Ars] 2022 Apr; Vol. 50 (3), pp. 168-174.

Clinical Outcomes of Implementing Evidence-Based Practice on Venous Thromboembolism Prevention for Cancer Patients In Qatar, A Retrospective Study

Autor: Elazzazy, S., Abd El Wahab, R., Negm, R., A/Wahid, M., Al Yafei, S., Zaidan, M., Al Hijji, I.

Publikováno v: In Clinical Therapeutics August 2015 37(8) Supplement:e22-e23

Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report.

Autor: Elazzazy S; Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., El-Geed HA, Al Yafei S

Publikováno v: International medical case reports journal [Int Med Case Rep J] 2013 Jan 04; Vol. 6, pp. 1-5. Date of Electronic Publication: 2013 Jan 04 (Print Publication: 2013).